Clinical Trial

A Phase 1 Study of JADE101 in Healthy Participants

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This is a Phase 1, first-in-human study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single ascending doses of JADE101 compared to placebo in healthy participants.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-07-09; most recent amendment 2025-12-11.
Status change: Recruiting → Active, Not Recruiting 2025-12-11
Status change: Not Yet Recruiting → Recruiting 2025-08-22
Trial Details
NCT Number NCT07059312
Lead Sponsor Jade Biosciences, Inc.
Conditions Healthy Volunteers
Enrollment 32 participants
Start Date 2025-08-17
Primary Completion 2026-10 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2025-12-18